Cited 11 times in
Fascin is involved in cancer cell invasion and is regulated by stromal factors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 장향란 | - |
dc.date.accessioned | 2020-02-11T06:12:50Z | - |
dc.date.available | 2020-02-11T06:12:50Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 1021-335X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/174589 | - |
dc.description.abstract | The tumor microenvironment plays an important role in cancer growth, invasion and metastasis. The stroma surrounding a tumor is known to contain a variety of factors that can increase angiogenesis, cancer growth and tumor progression. The aim of the present study was to determine the role of fascin in cancer growth and invasion and identify stromal factors involved in cancer progression. A fascin‑depleted cell line (fascindep) was used to observe the role of fascin in cancer invasion. Compared with wild‑type Mock cells, cancer cell invasion in Matrigel‑coated Transwell and three‑dimensional (3D) culture system were reduced by fascin depletion. Tumor cell growth in vivo was also significantly reduced in mice injected with fascindep cells. Notably, fascin expression was increased during Transwell invasion with Matrigel compared to Transwell invasion without Matrigel. TGF‑β1, EGF and IL‑1β significantly stimulated fascin expression. Such increased expression of fascin was also observed in cultured cells using conditioned media (CM) from cancer‑associated fibroblasts (CAFs). However, no significant change in fascin expression was observed using CM from normal fibroblasts (NFs). Stimulated expression of fascin by Matrigel and CAFs was reduced by biological specific inhibitor of TGF‑β1, EGF and IL‑1β. Compared with wild‑type Mock cells, the fascindep cell line showed low RhoA and NF‑κB activity, suggesting that RhoA and NF‑κB signals are involved in fascin expression. In conclusion, stromal factors are involved in cancer invasion and progression by activating intracellular signaling of cancer cells to increase fascin expression. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | D.A. Spandidos | - |
dc.relation.isPartOf | ONCOLOGY REPORTS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Cancer-Associated Fibroblasts/metabolism* | - |
dc.subject.MESH | Carrier Proteins/genetics | - |
dc.subject.MESH | Carrier Proteins/metabolism* | - |
dc.subject.MESH | Cell Culture Techniques | - |
dc.subject.MESH | Cell Line, Tumor | - |
dc.subject.MESH | Culture Media, Conditioned | - |
dc.subject.MESH | Gene Expression Regulation, Neoplastic/drug effects | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Mice | - |
dc.subject.MESH | Mice, Inbred BALB C | - |
dc.subject.MESH | Mice, Nude | - |
dc.subject.MESH | Microfilament Proteins/genetics | - |
dc.subject.MESH | Microfilament Proteins/metabolism* | - |
dc.subject.MESH | NF-kappa B p50 Subunit/metabolism | - |
dc.subject.MESH | Neoplasm Invasiveness/pathology | - |
dc.subject.MESH | Neoplasms/genetics | - |
dc.subject.MESH | Neoplasms/pathology* | - |
dc.subject.MESH | RNA, Small Interfering/metabolism | - |
dc.subject.MESH | Transforming Growth Factor beta1/antagonists & inhibitors | - |
dc.subject.MESH | Transforming Growth Factor beta1/metabolism | - |
dc.subject.MESH | Tumor Microenvironment* | - |
dc.subject.MESH | Xenograft Model Antitumor Assays | - |
dc.subject.MESH | rhoA GTP-Binding Protein/metabolism | - |
dc.title | Fascin is involved in cancer cell invasion and is regulated by stromal factors | - |
dc.type | Article | - |
dc.contributor.college | Research Institutes (연구소) | - |
dc.contributor.department | Oral Cancer Research Institute (구강종양연구소) | - |
dc.contributor.googleauthor | Xianglan Zhang | - |
dc.contributor.googleauthor | Il‑Hoon Cho | - |
dc.contributor.googleauthor | Ji Hyeon Park | - |
dc.contributor.googleauthor | Min Kyeong Lee | - |
dc.contributor.googleauthor | Young Sun Hwang | - |
dc.identifier.doi | 10.3892/or.2018.6847 | - |
dc.contributor.localId | A03489 | - |
dc.relation.journalcode | J02419 | - |
dc.identifier.eissn | 1791-2431 | - |
dc.identifier.pmid | 30542700 | - |
dc.identifier.url | https://www.spandidos-publications.com/or/41/1/465 | - |
dc.contributor.alternativeName | Zhang, Xiang Lan | - |
dc.contributor.affiliatedAuthor | 장향란 | - |
dc.citation.volume | 41 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 465 | - |
dc.citation.endPage | 474 | - |
dc.identifier.bibliographicCitation | ONCOLOGY REPORTS, Vol.41(1) : 465-474, 2019 | - |
dc.identifier.rimsid | 64379 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.